Sindrom Steven-Johnson
Pembimbing :
Prof. Dr. dr. Harsoyo N., DTM&H., Sp.A(K)
dr. Wistiani, M.Si. Med., Sp.A (K)
dr.Galuh Hardaningsih, Msi.Med, SpA
Ho HHF. Diagnosis and Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis The Hongkong Medical Diary.
2
Hongkong;2008;13(10):17-20
Harr T, French LE. Toxic epidermal necrolysis and steven johnson syndrome. orphanet journal of rare disease. 2010;5(39):4-11
Patogenesis
Hipersensitivitas tipe IV
Limfosit T tersensitisasi
Pengaktifan sel T
Penghancuran sel-sel
Alergi obat
Ag-Ab aktivitas komplemen
Akumulasi netrofil
Melepaskan enzim
Kerusakan enzim dan jaringan
ETIOLOGI
Sampai kini blm diketahui secara pasti
Merupakan eritema multiformis derajat berat : Eritema
multiformis mayor
Obat sistemik :
Penisilin & sintetiknya, streptomisin, sulfonamida, tetrasiklin,
analgetik/antipiretik : derivat salisil, pirazolon, metamizol,
metapiron, parasetamol
klorpromasin
karbamazepin, tegretol
kinin, antipirin, dan jamu
Penyebab lain :
Infeksi : bakteri, virus, jamur, parasit neoplasma
pasca vaksinasi
radiasi
makanan
6
Kel kulit
Kel mata
Tatalaksana
Kortikosteroid
IVIG
Imunosupresan
Kontroversi karena meningkatkan risiko infeksi
Antihistamin
Terapi topikal
Ghislain P-D, Roujeau j-C. Treatment of severe drug reactions: Stevens-Johnson Syndrome, Toxic eoidermal necrolysis and hypersensitivity syndrome. Dermatology online
Journal. 2002;8(1):5
Momin SB, Rosso JQD. Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis. The Journal of clinical and
aesthetic dermatology. 2009;2(21):51-7
Kortikosteroid
10
Law EH, Leung M. corticosteroid in Steven-Johnson Syndrome/Toxic epidermal nercrolysis: current evidence and implications for future research.
Annals of pharmacotherapy. 2014;49(3):334-42
11
Harsono A. Sindroma Steven Johnson : diagnosis dan penatalaksaan. Cointinuing Education Ilmu Kesehatan Anak XXXVI. 2006
12
Ghislain P-D, Roujeau j-C. Treatment of severe drug reactions: Stevens-Johnson Syndrome, Toxic eoidermal necrolysis and hypersensitivity syndrome. Dermatology online
Journal. 2002;8(1):5
13
14
15
IVIG
16
Karakteristik IVIG
Pengganti antibodi pada pasien imunodefisiensi
primer
Derivat plasma yg berasal dari bbrp donor
Sebagian besar mrp Ig G
Mekanisme aksi kompleks : mempengaruhi fungsi
sel T, sel B, serta monosit memblok ikatan Fas
(CD95) dengan ligan nya (CD95 L)
Momin SB, Rosso JQD. Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis.
The Journal of clinical and aesthetic dermatology. 2009;2(21):51-7
17
18
19
21
Antihistamin
22
Antihistamin
23
24
Terapi Topikal
25
Ghislain P-D, Roujeau j-C. Treatment of severe drug reactions: Stevens-Johnson Syndrome, Toxic eoidermal necrolysis and hypersensitivity syndrome. Dermatology online
Journal. 2002;8(1):5
26
Terima Kasih
Mohon Bimbingan dan Asupan
27
28
Imunopatogenesis
kelainan yg dimediasi sel T
early stages of disease :
CD8+ lymphocytes in the blister fluid and epidermis and CD4+ lymphocytes
in the dermis
Monocytes in the epidermis
later stages of the disease:
relative decrease in lymphocytes and increase in monocytes
Cytotoxic Tlymphocytes kill other cells by inducing apoptosis, which is an
immunologically silent process that does not trigger an inflammatory response
and occurs very rapidly
cascade of intracellular enzymes called caspases is activated when cytotoxic Tlymphocytes come in contact with target cells.
The caspase cascade is induced either through the perforin/granzyme or the Fas
(CD95)-Fas ligand (FasL/CD95L) pathway
Both Fas- FasL and perforin/granzyme are involved in triggering apoptosis
29